Online citations, reference lists, and bibliographies.
← Back to Search

Cytoreductive Surgery Combined With Intraoperative Hyperthermic Intrathoracic Chemotherapy For Stage I Malignant Pleural Mesothelioma

S. van Ruth, P. Baas, R. Haas, E. Rutgers, V. Verwaal, F. Zoetmulder
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
AbstractBackground:Malignant pleural mesothelioma (MPM) is a disease mostly confined to the thoracic cavity. Untreated, the median survival is <1 year. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy is used to kill residual tumor cells on the surface of the thoracic cavity while having limited systemic side effects. Methods:From August 1998 to August 2001, 22 patients with stage I MPM were included in this study. Two patients were irresectable at operation because of extrathoracic tumor growth. Twenty procedures were performed. After cytoreduction, a perfusion was performed with cisplatin and doxorubicin at 40°C to 41°C for 90 minutes. Adjuvant radiotherapy was given to surgical scars and drainage tracts. Results:There was no perioperative mortality, but significant morbidity was seen in 13 patients (65%), including bronchopleural fistula, diaphragm rupture, wound dehiscence, persistent air leakage, and chylous effusion. No hair loss or leucopenia was noticed. The median follow-up was 14 months. The median survival (Kaplan-Meier) was 11 months, with a 1-year survival of 42%. A favorable pharmacokinetic ratio was observed for both cisplatin and doxorubicin. Conclusions:Cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy for stage I MPM is feasible. However, this treatment is accompanied by considerable morbidity. Survival data were less encouraging.
This paper references
Regional pharmacokinetic selectivity of intrapleural cisplatin.
G. Bogliolo (1991)
Hyperthermic pleural perfusion with cisplatin
A. Yellin (2001)
A new device for the treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report.
P. Y. Carry (1993)
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
R. Heelan (1999)
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
V. Rusch (1992)
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.
C. Boutin (1995)
Clinical hyperthermia and chemotherapy.
F. Storm (1989)
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
P. Ruffié (1989)
A review of chemotherapy trials for malignant mesothelioma.
C. Ryan (1998)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
Malignant pleural mesothelioma.
L. Ho (2001)
Extrapleural Nodal Status, and Cell Type Determine Postoperative Long-Term Survival in Tri modality Therapy of Malignant Pleural Mesothelioma: Results in 183 Patients
D J Sugarbaker (1999)
Hyperthermic Pleural Perfusion With Cisplatin
DA Yellin A. Simansky (2001)
Clinical hyperthermia and chemotherapy.
Storm Fk (1989)
Management of malignant pleural mesothelioma: a critical review
Y. Lee (2000)
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
Current approach to malignant mesothelioma of the pleura.
J. Aisner (1995)
Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
E. de Bree (2002)
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
V. Rusch (1999)
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
V. Rusch (1994)
Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma.
V. Rusch (1993)
Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.
G. B. Ratto (1999)

This paper is referenced by
A better way for a cancer cell to die.
R. Lake (2006)
Intrathoracic Thermochemoradiotherapy for the Treatment of Locally- Advanced Malignant Pleural Mesothelioma
T. Itazawa (2004)
Oncotargets and Therapy
L. Yu ()
on Novel Therapies
Andrew R. Haas (2013)
La chirurgie pleurale « thérapeutique »
N. Vénissac (2006)
Intraoperative Chemotherapie nach radikaler Pleurektomie oder extrapleuraler Pneumonektomie
M. Ried (2012)
Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.
Y. Matsuzaki (2008)
Intracavitary radioimmunotherapy to treat solid tumors.
F. Aarts (2008)
Malignant Pleural Mesothelioma
S. Raja (2011)
Innovative therapies: intraoperative intracavitary chemotherapy.
M. Chang (2004)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
M. Carbone (2019)
Chemotherapy Combined with Hyperthermia Improves the Prognosis for Non-small-cell Lung Cancer
Atsushi Toki (2009)
Zytoreduktive Chirurgie und hypertherme intrathorakale Chemotherapieperfusion
H. Hofmann (2010)
The Development of the Brigham and Women’s Multimodality Treatment Plan for Malignant Pleural Mesothelioma: A Model for Improving the Treatment of Rare Diseases
M. Jaklitsch (2005)
Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Anh Dang (2007)
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
L. Lang-Lazdunski (2015)
Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.
A. Tsao (2009)
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
Update on malignant mesothelioma.
K. Antman (2005)
Behandlung maligner Tumoren der Pleura
M. Ried (2012)
Management of malignant pleural mesothelioma.
S. West (2006)
Management of Pleural Effusions in Mesothelioma
S. Andaz (2005)
Surgical Treatment in the Management of Malignant Pleural Mesothelioma: A Single Institution’s Experience
J. Sandick (2008)
Clinical Results of Systemic Chemotherapy Combined with Regional Hyperthermia
T. Ohguri (2007)
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
A. Haas (2013)
Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei
T. Chua (2009)
Limited Cardiotoxicity after Extensive Thoracic Surgery and Intraoperative Hyperthermic Intrathoracic Chemotherapy with Doxorubicin and Cisplatin
E. Bree (2007)
Hyperthermic Intrapleural Chemotherapy in Pleural Malignancy
Frans A. N. Zoetmulder (2007)
Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion
C. Kerscher (2014)
Chemotherapy for malignant mesothelioma.
P. Baas (2005)
of Thoracic Surgeons for management of Malignant Pleural Mesothelioma
A. Scherpereel (2009)
MESOMARK(®) in vitro diagnostic test for mesothelioma.
Zhong-Qian Li (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar